Haemonetics (HAE) Tops Q1 EPS by 32c

Haemonetics (NYSE: HAE) reported Q1 EPS of $1.05, $0.32 better than the analyst estimate of $0.73. Revenue for the quarter came in at $311.3 million versus the consensus estimate of $292.69 million.

For earnings history and earnings-related data on Haemonetics (HAE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c